These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32285543)

  • 1. Convergent and Discriminant Validity of the Serbian Version of the Central Sensitization Inventory.
    Knezevic A; Neblett R; Colovic P; Jeremic-Knezevic M; Bugarski-Ignjatovic V; Klasnja A; Pantelinac S; Pjevic M
    Pain Pract; 2020 Sep; 20(7):724-736. PubMed ID: 32285543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-Cultural Adaptation and Psychometric Validation of the Serbian Version of the Central Sensitization Inventory.
    Knezevic A; Neblett R; Jeremic-Knezevic M; Tomasevic-Todorovic S; Boskovic K; Colovic P; Cuesta-Vargas A
    Pain Pract; 2018 Apr; 18(4):463-472. PubMed ID: 28777895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-cultural Adaptation and Psychometric Properties of the Greek Version of the Central Sensitization Inventory.
    Bilika P; Neblett R; Georgoudis G; Dimitriadis Z; Fandridis E; Strimpakos N; Kapreli E
    Pain Pract; 2020 Feb; 20(2):188-196. PubMed ID: 31605651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the Central Sensitization Inventory (CSI) as a treatment outcome measure for patients with chronic spinal pain disorder in a functional restoration program.
    Neblett R; Hartzell MM; Williams M; Bevers KR; Mayer TG; Gatchel RJ
    Spine J; 2017 Dec; 17(12):1819-1829. PubMed ID: 28619687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-cultural adaptation and psychometric properties of the Arabic version of the Central Sensitization Inventory in people with chronic musculoskeletal pain.
    Tamboosi SE; Alzahrani H; Alshehri FH; Alzhrani M; S Alshehri Y
    PeerJ; 2024; 12():e18251. PubMed ID: 39399430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-cultural adaptation and validation of the Finnish version of the central sensitization inventory and its relationship with dizziness and postural control.
    Mikkonen J; Luomajoki H; Airaksinen O; Neblett R; Selander T; Leinonen V
    BMC Neurol; 2021 Mar; 21(1):141. PubMed ID: 33784969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing Clinically Relevant Severity Levels for the Central Sensitization Inventory.
    Neblett R; Hartzell MM; Mayer TG; Cohen H; Gatchel RJ
    Pain Pract; 2017 Feb; 17(2):166-175. PubMed ID: 26989894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological Distress and Widespread Pain Contribute to the Variance of the Central Sensitization Inventory: A Cross-Sectional Study in Patients with Chronic Pain.
    van Wilgen CP; Vuijk PJ; Kregel J; Voogt L; Meeus M; Descheemaeker F; Keizer D; Nijs J
    Pain Pract; 2018 Feb; 18(2):239-246. PubMed ID: 28449376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convergent Validity of the Dutch Central Sensitization Inventory: Associations with Psychophysical Pain Measures, Quality of Life, Disability, and Pain Cognitions in Patients with Chronic Spinal Pain.
    Kregel J; Schumacher C; Dolphens M; Malfliet A; Goubert D; Lenoir D; Cagnie B; Meeus M; Coppieters I
    Pain Pract; 2018 Jul; 18(6):777-787. PubMed ID: 29222851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of the Central Sensitization Inventory compared with traditional measures of disease severity in fibromyalgia.
    Salaffi F; Farah S; Mariani C; Sarzi-Puttini P; Di Carlo M
    Pain Pract; 2022 Nov; 22(8):702-710. PubMed ID: 36097821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-Cultural Adaptation and Psychometric Properties of the European Portuguese Version of the Central Sensitization Inventory in Adolescents With Musculoskeletal Chronic Pain.
    Andias R; Silva AG
    Pain Pract; 2020 Jun; 20(5):480-490. PubMed ID: 32022985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-cultural adaptation and validity of the Italian version of the Central Sensitization Inventory.
    Chiarotto A; Viti C; Sulli A; Cutolo M; Testa M; Piscitelli D
    Musculoskelet Sci Pract; 2018 Oct; 37():20-28. PubMed ID: 29966856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross cultural adaptation, validity, and reliability of Central Sensitization Inventory in Arabic language.
    Madi M; Hamzeh H; Abujaber S; Altubasi I
    Disabil Rehabil; 2022 Dec; 44(25):8075-8083. PubMed ID: 34813384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translation, cross-cultural adaptation, and measurement properties of the Nepali version of the central sensitization inventory (CSI).
    Sharma S; Jha J; Pathak A; Neblett R
    BMC Neurol; 2020 Jul; 20(1):286. PubMed ID: 32718330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-cultural adaptation and psychometric validation of the Persian version of the central sensitization inventory.
    Noorollahzadeh K; Kahrizi S; Fesharaki MG; Heidarian M; Neblett R; Behzadipour S
    Musculoskelet Sci Pract; 2021 Feb; 51():102314. PubMed ID: 33360651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric properties of the Turkish version of Central Sensitization Inventory-9 in patients with chronic musculoskeletal pain.
    Bazancir-Apaydin Z; Sari F
    Int J Rehabil Res; 2024 Jun; 47(2):122-128. PubMed ID: 38470712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-cultural adaptation and validation of the German Central Sensitization Inventory (CSI-GE).
    Klute M; Laekeman M; Kuss K; Petzke F; Dieterich A; Leha A; Neblett R; Ehrhardt S; Ulma J; Schäfer A
    BMC Musculoskelet Disord; 2021 Aug; 22(1):708. PubMed ID: 34407773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development and psychometric validation of the central sensitization inventory.
    Mayer TG; Neblett R; Cohen H; Howard KJ; Choi YH; Williams MJ; Perez Y; Gatchel RJ
    Pain Pract; 2012 Apr; 12(4):276-85. PubMed ID: 21951710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutoff Value for Short Form of Central Sensitization Inventory.
    Tanaka K; Nishigami T; Mibu A; Manfuku M; Yono S; Yukioka M; Miki K
    Pain Pract; 2020 Mar; 20(3):269-276. PubMed ID: 31638741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Japanese version of the Central Sensitization Inventory in patients with musculoskeletal disorders.
    Tanaka K; Nishigami T; Mibu A; Manfuku M; Yono S; Shinohara Y; Tanabe A; Ono R
    PLoS One; 2017; 12(12):e0188719. PubMed ID: 29216211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.